Adherium Limited (ASX:ADR)

Market Cap	548.87M +5,791.8%
Revenue (ttm)	2.10M +157.0%
Net Income	-14.16M
EPS	-0.00
Shares Out	5.49B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	500
Open	0.1000
Previous Close	0.1000
Day's Range	0.1000 - 0.1000
52-Week Range	0.0950 - 0.8000
Beta	1.04
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 4, 2026

About Adherium

Adherium Limited, a digital health company, develops, manufactures, and supplies digital health technologies that address sub-optimal medication use in chronic diseases in New Zealand, Australia, Europe, and North America. The company offers Hailie Smartinhaler, a system for management of chronic respiratory conditions, including asthma and chronic obstructive pulmonary disease. It also provides Hailie Smartinhaler sensors; Hailie Solution; and Hailie Remote Patient Monitoring (RPM) Solution. The company was founded in 2001 and is based in Melb...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2001
• Employees: 40
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: ADR

Financial Performance

In fiscal year 2026, Adherium's revenue was 2.10 million, an increase of 157.02% compared to the previous year's 817,237. Losses were -14.16 million, 11.7% more than in 2025.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 4, 2026

Data Sources Report a data error